Literature DB >> 19801680

Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes.

Vania De Arcangelis1, Ruijie Liu, Dagoberto Soto, Yang Xiang.   

Abstract

cAMP and protein kinase A (PKA) activation represents a key signaling mechanism upon beta-adrenergic stimulation under stress. Both beta(1)- and beta(2)-adrenoreceptor (ARs) subtypes induce cAMP accumulation, yet play distinct roles in cardiac contraction and myocyte apoptosis. Differences in controlling cAMP/PKA activities through the assembly of complexes between the receptors and cAMP-specific phosphodiesterases contribute to the distinct biological outcomes. Here, we demonstrate that beta(2)ARs form signaling complexes with a set of PDE4D isoforms expressed in cardiac myocytes. PDE4D9 and PDE4D8 bind to the beta(2)AR at resting conditions; however, agonist stimulation induces dissociation of PDE4D9 from the receptor but recruitment of PDE4D8 to the receptor. Agonist stimulation also induces recruitment of PDE4D5 to the beta(2)AR. Moreover, the receptor-associated PDE4D isoforms play distinct roles in controlling cAMP activities and regulating the PKA phosphorylation of the receptor and myocyte contraction rate responses. Knockdown of PDE4D9 with short hairpin RNA enhances the beta(2)AR-induced cAMP signaling, whereas knockdown of PDE4D8 only slightly prolongs the receptor-induced cAMP signaling in myocytes. Inhibition of PDE4D9 and PDE4D5 enhances the base-line levels of contraction rates, whereas inhibition of PDE4D9 and PDE4D8 enhances the maximal contraction rate increases upon activation of beta(2)AR. Our data underscore the complex regulation of intracellular cAMP by beta(2)AR-associated phosphodiesterase enzymes to enforce the specificity of the receptor signaling for physiological responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801680      PMCID: PMC2797152          DOI: 10.1074/jbc.M109.020388

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2.

Authors:  M A Davare; V Avdonin; D D Hall; E M Peden; A Burette; R J Weinberg; M C Horne; T Hoshi; J W Hell
Journal:  Science       Date:  2001-07-06       Impact factor: 47.728

2.  Localized cAMP-dependent signaling mediates beta 2-adrenergic modulation of cardiac excitation-contraction coupling.

Authors:  Y Y Zhou; H Cheng; K Y Bogdanov; C Hohl; R Altschuld; E G Lakatta; R P Xiao
Journal:  Am J Physiol       Date:  1997-09

3.  Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue.

Authors:  Wito Richter; S-L Catherine Jin; Marco Conti
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

4.  Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

Authors:  Y Daaka; L M Luttrell; R J Lefkowitz
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

5.  Phosphodiesterase 4D is required for beta2 adrenoceptor subtype-specific signaling in cardiac myocytes.

Authors:  Yang Xiang; Fabio Naro; Maria Zoudilova; S-L Catherine Jin; Marco Conti; Brian Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-11       Impact factor: 11.205

6.  Dynamic protein kinase a activities induced by beta-adrenoceptors dictate signaling propagation for substrate phosphorylation and myocyte contraction.

Authors:  Dagoberto Soto; Vania De Arcangelis; Jin Zhang; Yang Xiang
Journal:  Circ Res       Date:  2009-02-12       Impact factor: 17.367

7.  Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.

Authors:  Tuan M Tran; Jackie Friedman; Eyad Qunaibi; Faiza Baameur; Robert H Moore; Richard B Clark
Journal:  Mol Pharmacol       Date:  2004-01       Impact factor: 4.436

8.  Caveolar localization dictates physiologic signaling of beta 2-adrenoceptors in neonatal cardiac myocytes.

Authors:  Yang Xiang; Vitalyi O Rybin; Susan F Steinberg; Brian Kobilka
Journal:  J Biol Chem       Date:  2002-07-03       Impact factor: 5.157

9.  Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins.

Authors:  Stephen J Perry; George S Baillie; Trudy A Kohout; Ian McPhee; Maria M Magiera; Kok Long Ang; William E Miller; Alison J McLean; Marco Conti; Miles D Houslay; Robert J Lefkowitz
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

10.  beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.

Authors:  George S Baillie; Arvind Sood; Ian McPhee; Irene Gall; Stephen J Perry; Robert J Lefkowitz; Miles D Houslay
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more
  34 in total

1.  Equilibrium between adenylyl cyclase and phosphodiesterase patterns adrenergic agonist dose-dependent spatiotemporal cAMP/protein kinase A activities in cardiomyocytes.

Authors:  Vania De Arcangelis; Shubai Liu; Dawen Zhang; Dagoberto Soto; Yang K Xiang
Journal:  Mol Pharmacol       Date:  2010-06-07       Impact factor: 4.436

Review 2.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

Review 3.  PDE4 as a target for cognition enhancement.

Authors:  Wito Richter; Frank S Menniti; Han-Ting Zhang; Marco Conti
Journal:  Expert Opin Ther Targets       Date:  2013-07-25       Impact factor: 6.902

Review 4.  Different subcellular populations of L-type Ca2+ channels exhibit unique regulation and functional roles in cardiomyocytes.

Authors:  Jabe M Best; Timothy J Kamp
Journal:  J Mol Cell Cardiol       Date:  2011-08-23       Impact factor: 5.000

Review 5.  Cyclic AMP synthesis and hydrolysis in the normal and failing heart.

Authors:  Aziz Guellich; Hind Mehel; Rodolphe Fischmeister
Journal:  Pflugers Arch       Date:  2014-04-24       Impact factor: 3.657

6.  Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels.

Authors:  C Blake Nichols; Charles F Rossow; Manuel F Navedo; Ruth E Westenbroek; William A Catterall; Luis F Santana; G Stanley McKnight
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

Review 7.  Compartmentalization of beta-adrenergic signals in cardiomyocytes.

Authors:  Yang K Xiang
Journal:  Circ Res       Date:  2011-07-08       Impact factor: 17.367

8.  Phosphodiesterase 4B in the cardiac L-type Ca²⁺ channel complex regulates Ca²⁺ current and protects against ventricular arrhythmias in mice.

Authors:  Jérôme Leroy; Wito Richter; Delphine Mika; Liliana R V Castro; Aniella Abi-Gerges; Moses Xie; Colleen Scheitrum; Florence Lefebvre; Julia Schittl; Philippe Mateo; Ruth Westenbroek; William A Catterall; Flavien Charpentier; Marco Conti; Rodolphe Fischmeister; Grégoire Vandecasteele
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

Review 9.  Therapeutic potential of PDE modulation in treating heart disease.

Authors:  Walter Knight; Chen Yan
Journal:  Future Med Chem       Date:  2013-09       Impact factor: 3.808

Review 10.  Compartmentalization of β-adrenergic signals in cardiomyocytes.

Authors:  Qin Fu; Xiongwen Chen; Yang K Xiang
Journal:  Trends Cardiovasc Med       Date:  2013-03-23       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.